LANXESS Croissance future
Future contrôle des critères 0/6
LANXESS devrait augmenter ses bénéfices et son chiffre d'affaires de 63.3% et de 3.5% par an respectivement. Le BPA devrait croître de de 62.5% par an. Le rendement des capitaux propres devrait être -1.5% dans 3 ans.
Informations clés
63.3%
Taux de croissance des bénéfices
62.51%
Taux de croissance du BPA
| Chemicals croissance des bénéfices | 43.0% |
| Taux de croissance des recettes | 3.5% |
| Rendement futur des capitaux propres | -1.54% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 08 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
Article d'analyse • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...
Mise à jour de l'analyse • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Mise à jour de l'analyse • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Mise à jour de l'analyse • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.
Mise à jour de l'analyse • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Mise à jour de l'analyse • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Mise à jour de l'analyse • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Mise à jour de l'analyse • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Mise à jour de l'analyse • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Mise à jour de l'analyse • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Article d'analyse • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Mise à jour de l'analyse • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Article d'analyse • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Mise à jour de l'analyse • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Mise à jour de l'analyse • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Mise à jour de l'analyse • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Mise à jour de l'analyse • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Mise à jour de l'analyse • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Mise à jour de l'analyse • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Article d'analyse • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Nouvelle analyse • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Article d'analyse • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Article d'analyse • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d'analyse • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Article d'analyse • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d'analyse • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Article d'analyse • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Article d'analyse • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Article d'analyse • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Article d'analyse • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Article d'analyse • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d'analyse • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Article d'analyse • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d'analyse • Nov 01
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €20.51 based on Dividend Discount Model Current share price of...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 6,103 | -3 | 173 | 540 | 12 |
| 12/31/2027 | 5,931 | -67 | 155 | 487 | 15 |
| 12/31/2026 | 5,857 | -210 | 71 | 361 | 10 |
| 3/31/2026 | 5,450 | -661 | 52 | 367 | N/A |
| 12/31/2025 | 5,673 | -577 | -30 | 289 | N/A |
| 9/30/2025 | 5,888 | -243 | 112 | 432 | N/A |
| 6/30/2025 | 6,148 | -165 | 112 | 441 | N/A |
| 3/31/2025 | 6,360 | -136 | 164 | 490 | N/A |
| 12/31/2024 | 6,366 | -177 | 188 | 508 | N/A |
| 9/30/2024 | 6,319 | -690 | 71 | 377 | N/A |
| 6/30/2024 | 6,322 | -822 | 407 | 708 | N/A |
| 3/31/2024 | 6,422 | -951 | 323 | 629 | N/A |
| 12/31/2023 | 6,714 | -843 | 512 | 838 | N/A |
| 9/30/2023 | 7,251 | -280 | 433 | 785 | N/A |
| 6/30/2023 | 7,835 | -65 | 32 | 414 | N/A |
| 3/31/2023 | 8,056 | 128 | 94 | 501 | N/A |
| 12/31/2022 | 8,088 | 184 | -248 | 159 | N/A |
| 9/30/2022 | 7,794 | 191 | -136 | 296 | N/A |
| 6/30/2022 | 7,190 | 147 | -60 | 372 | N/A |
| 3/31/2022 | 6,660 | 146 | -228 | 194 | N/A |
| 12/31/2021 | 6,101 | 116 | -17 | 407 | N/A |
| 9/30/2021 | 5,925 | 119 | -62 | 371 | N/A |
| 6/30/2021 | 5,805 | 105 | 7 | 444 | N/A |
| 3/31/2021 | 5,772 | 863 | 72 | 515 | N/A |
| 12/31/2020 | 6,104 | 892 | 129 | 585 | N/A |
| 9/30/2020 | 6,237 | 883 | 113 | 590 | N/A |
| 6/30/2020 | 6,480 | 938 | 185 | 677 | N/A |
| 3/31/2020 | 6,768 | 231 | 200 | 713 | N/A |
| 12/31/2019 | 6,802 | 255 | N/A | 643 | N/A |
| 9/30/2019 | 6,559 | 266 | N/A | 685 | N/A |
| 6/30/2019 | 6,641 | 243 | N/A | 665 | N/A |
| 3/31/2019 | 6,746 | 212 | N/A | 595 | N/A |
| 12/31/2018 | 6,824 | 190 | N/A | 586 | N/A |
| 9/30/2018 | 7,066 | 144 | N/A | 603 | N/A |
| 6/30/2018 | 6,990 | 138 | N/A | 737 | N/A |
| 3/31/2018 | 6,873 | 63 | N/A | 881 | N/A |
| 12/31/2017 | 6,530 | 23 | N/A | 868 | N/A |
| 9/30/2017 | 6,810 | 73 | N/A | 692 | N/A |
| 6/30/2017 | 7,021 | 83 | N/A | 627 | N/A |
| 3/31/2017 | 7,252 | 166 | N/A | 651 | N/A |
| 12/31/2016 | 7,699 | 192 | N/A | 689 | N/A |
| 9/30/2016 | 7,590 | 205 | N/A | 882 | N/A |
| 6/30/2016 | 7,622 | 184 | N/A | 768 | N/A |
| 3/31/2016 | 7,784 | 196 | N/A | 707 | N/A |
| 12/31/2015 | 7,902 | 165 | N/A | 692 | N/A |
| 9/30/2015 | 8,000 | 82 | N/A | 751 | N/A |
| 6/30/2015 | 8,087 | 76 | N/A | 762 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: LXS devrait rester non rentable au cours des 3 prochaines années.
Bénéfices vs marché: LXS devrait rester non rentable au cours des 3 prochaines années.
Croissance élevée des bénéfices: LXS devrait rester non rentable au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de LXS ( 3.5% par an) devrait croître plus lentement que le marché de German ( 6.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de LXS ( 3.5% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: LXS devrait être non rentable dans 3 ans.
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/13 18:10 |
| Cours de l'action en fin de journée | 2026/05/13 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
LANXESS Aktiengesellschaft est couverte par 35 analystes. 15 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| James Knight | Barclays |
| Anil Shenoy | Barclays |
| Andres Castanos-Mollor | Berenberg |